Provided by Tiger Trade Technology Pte. Ltd.

Amylyx Pharmaceuticals

34.69
-0.0530-0.15%
Volume:30.94K
Turnover:1.07M
Market Cap:3.86B
PE:-24.24
High:34.88
Open:34.78
Low:34.41
Close:34.74
52wk High:41.14
52wk Low:9.15
Shares:111.19M
Float Shares:109.51M
Volume Ratio:1.25
T/O Rate:0.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4309
EPS(LYR):-1.5305
ROE:-74.73%
ROA:-44.13%
PB:16.13
PE(LYR):-22.66

Loading ...

Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Sep 10, 2025

Major Issues Report

Form 8-K - Current report
Aug 27, 2025

Major Issues Report

Form 8-K - Current report
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report